Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 7, 2011

Premium

GenMark Diagnostics this week announced the appointment of Hany Massarany as president and CEO. Massarany will also join GenMark's board.

Massarany has served as president of Ventana Medical Systems and Head of Roche Tissue Diagnostics since 2009. Ventana was acquired by Roche in February 2008 for about $3.4 billion.

Prior to that, he held various positions with Ventana, including COO, executive vice president of worldwide operations, senior vice president of corporate strategy and development, and vice president of North American commercial operations.

Prior to Ventana, Massarany held executive management positions with Bayer Diagnostics and Chiron Diagnostics. He holds a BS in microbiology and immunology from Monash University and an MBA from Melbourne University.


Fluidigm said this week that Evan Jones has been appointed to the company's board of directors, and will join the board's compensation committee.

Jones is the managing member of jVen Capital, a life sciences investment firm. Prior to that, he was co-founder, chairman, and CEO of Digene. He is currently executive chairman of Opgen; and a board member of CAS Medical Systems and Veracyte.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more